Clinical Trial Imaging Market: Growing at a CAGR of 6.30% between 2016 and 2021

Zion Research has published a new report titled “Clinical Trial Imaging (Software And Services) By Technology (Echo, PET, MRI, X Ray, CT, Ultrasound And Other) Market For Biotech Companies, Pharmaceuticals, Research Center, Hospitals, And Other End-Users: Global Industry Perspective, Comprehensive Analysis And Forecast, 2015 – 2021” According to the report, the global clinical trial imaging market was valued at approximately USD 731.9  million in 2015 and is expected to reach approximately USD 1,052.9 million by 2021, growing at a CAGR of around 6.30% between 2016 and 2021.

Request Sample Report:

Imaging is the technique of generating visual representations of an object or body. Clinical trial imaging uses imaging technology in clinical trials for viewing the interior parts of body. The images obtained from clinical trial imaging are used for diagnose, examine and reveal human body. Screening imaging clinical trials, diagnostic imaging clinical trials and image-guided interventional clinical trials are the key types include in clinical trial imaging. Clinical trial imaging provides quick, detail, accurate diagnosis.

Increasing geriatric population and growing occurrences of chronic diseases, are some of the major factors driving the clinical trials imaging market. Growth in pharmaceutical industry is a major factor that is expected to help the growth of the clinical trial imaging in the years to come. Government support and investments coupled with research and development activities especially in countries such as U.S. and UK is anticipated to boost the market growth in the near future. However, high cost of machinery and its installation is a major restraining factor for the market growth.

The clinical trial imaging market is segmented on the basis of service and software. Service accounted for a large chunk of the global clinical trial imaging market in 2015. Software is another leading segment and it accounted for 35.2% share of total market in 2015. This growth is mainly attributed to high investment in R&D activities coupled with government support.

Do Inquiry before buying:

Based on technology, the global clinical trial imaging market is segmented as echo, PET, MRI, X-Ray, CT, and ultrasound and others.  The CT segment dominated the market with over 31.0% share of the total market in 2015. MRI, PET and ultrasound are also accounted for significant share owing to the increasing disabled and aging populations who are commonly diagnosed with different disease and other complications.

Some of the key end-users of the clinical trial imaging market include biotech companies, pharmaceutical, research centers, hospitals and others. Among  all end-users, pharmaceutical was the leading segment and it accounted for over 45.0% share of the total revenue generated in 2015. Biotech companies another key outlet of the market and expected to exhibit significant growth within the forecast period. This growth is mainly due to rising development in bio-pharmaceutical industries.

North America dominated the clinical trial imaging market and accounted for over 44.0% share of the global market in 2015. North America was followed by Europe in terms of revenue. The clinical trial imaging market in Asia Pacific region is expected to exhibit significant growth owing to rising government support and rapid growth in population. Latin America and Middle East & Africa are also expected to experience significant growth of clinical trial imaging market in the years to come.

Browse detail report at:

Some of the key players of the global clinical trial imaging market include Cardiovascular Imaging Technologies, VirtualScopic, Biomedical Systems, BioClinica, Intrinsic Imaging LLC, Prism Clinical Imaging, PAREXEL International Corporation, and ICON among others.

This report segments the global clinical trial imaging market as follows:

Clinical Trials Imaging Market: Product Segment Analysis

  • Service
  • Software

Clinical Trials Imaging Market: Technology Segment Analysis

  • X-ray
  • CT
  • MRI
  • PET
  • Echo
  • Ultrasound
  • Other technologies

Clinical Trials Imaging Market: End user Segment Analysis

  • Biotech companies
  • Pharmaceutical
  • Research centers
  • Hospitals
  • Other end users

Read Report TOC:

Clinical trial imaging Market: Regional Segment Analysis

  • North America
    • US
  • Europe
    • Germany
    • France
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

About Us

Zion Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Zion Research experienced team of Analysts, Researchers, and Consultants uses proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact US:

Joel John
3422 SW 15 Street,Suit #8138
Deerfield Beach,Florida 33442
United States
Toll Free: +1-855-465-4651 (USA-CANADA)
Tel: +1-386-310-3803